Develops genome analysis systems for genetic disease and cancer research.
Jun 2026Revenue $30.2M/yrExpenses $62.4M/yr
No trendCash runway ≈ 6 months from Jun 2026
Figures by year
When will Bionano Genomics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $30.2M and expenses $62.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $28.5M | $61.8M | −$33.3M |
| Dec 2024 | $30.8M | $135M | −$104M |
| Dec 2023 | $36.1M | $251M | −$215M |
| Dec 2022 | $27.8M | $160M | −$132M |
| Dec 2021 | $18.0M | $95.1M | −$77.1M |
| Dec 2020 | $8.50M | $47.1M | −$38.6M |
| Dec 2019 | $10.1M | $36.0M | −$25.9M |
| Dec 2018 | $12.0M | $32.4M | −$20.4M |
| Dec 2017 | $9.51M | $32.7M | −$23.2M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.